Phase 1 Trial of the Topical Microbicide BufferGel: Safety Results From Four International Sites

200185 citationsJournal Article

Authors

BufferGel appears to be safe and well tolerated by the cervicovaginal epithelium. Its effect on BV and yeasts merits further study.

Good health and well-being

Published in: JAIDS Journal of Acquired Immune Deficiency Syndromes

Volume 26, Issue 1, pp. 21-27

Field-Weighted Citation Impact: 4.37